Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Age
14–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Aged between 14 and 60 years.
Clinically and postoperatively pathologically diagnosed with a facial benign tumor (e.g., melanocytic nevus, sebaceous cyst, seborrheic keratosis, etc.) and having undergone standard surgical treatment.
Voluntary participation in this study with written informed consent obtained.
Commitment to comply with all study protocols and to complete all follow-up visits and data collection procedures.
You may not be if
Clinically or postoperatively diagnosed with a facial malignant tumor.
Wounds requiring staged excision or planned for secondary intention healing.
Surgical site located on or adjacent to the mucosal surface.
Known history of allergy to any medications or dressings to be used during or after surgery.
Presence of systemic diseases that significantly impair wound healing (e.g., poorly controlled diabetes, immunodeficiency disorders, active infections).
Current use of medications affecting wound healing or scar formation (e.g., long-term systemic corticosteroids, immunosuppressants).
Pregnancy or lactation.
Refusal to provide written informed consent, or anticipated inability to comply with study follow-up and data collection.
Concurrent participation in another interventional clinical trial.
Any other condition deemed by the investigator as likely to interfere with study results or increase participant risk.
Clareo Health | Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery
